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Abstract
Background: Enterococcus faecium has globally emerged as a cause of hospital-acquired infections
with high colonization rates in hospitalized patients. The enterococcal surface protein Esp,
identified as a potential virulence factor, is specifically linked to nosocomial clonal lineages that are
genetically distinct from indigenous E. faecium strains. To investigate whether Esp facilitates
bacterial adherence and intestinal colonization of E. faecium, we used human colorectal
adenocarcinoma cells (Caco-2 cells) and an experimental colonization model in mice.
Results: No differences in adherence to Caco-2 cells were found between an Esp expressing strain
of  E. faecium (E1162) and its isogenic Esp-deficient mutant (E1162Δesp). Mice, kept under
ceftriaxone treatment, were inoculated orally with either E1162, E1162Δesp  or both strains
simultaneously. Both E1162 and E1162Δesp were able to colonize the murine intestines with high
and comparable numbers. No differences were found in the contents of cecum and colon. Both
E1162 and E1162Δesp were able to translocate to the mesenteric lymph nodes.
Conclusion: These results suggest that Esp is not essential for Caco-2 cell adherence and intestinal
colonization or translocation of E. faecium in mice.
Background
Enterococci are normal inhabitants of the human gas-
trointestinal (GI) tract, but have emerged as important
nosocomial pathogens with high-level resistance to anti-
biotics, such as ampicillin, aminoglycosides, and vanco-
mycin [1]. They can cause a wide spectrum of diseases,
including bacteremia, peritonitis, surgical wound infec-
tions, urinary tract infections, endocarditis, and a variety
of device-related infections [1-11]. The majority of the
enterococcal infections are caused by Enterococcus faecalis.
However, in parallel with the increase in nosocomial ente-
rococcal infections, a partial replacement of E. faecalis by
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Enterococcus faecium has occurred in European and United
States hospitals [12-14]http://www.earss.rivm.nl.
Molecular epidemiological studies indicated that E. fae-
cium isolates responsible for the majority of nosocomial
infections and hospital outbreaks are genetically distinct
from indigenous intestinal isolates [15,16]. Recent studies
revealed intestinal colonization rates with these hospital-
acquired E. faecium as high as 40% in hospital wards,
while colonization in healthy people appeared to be
almost absent [13,15,16]. It is assumed that adherence to
mucosal surfaces is a key process for bacteria to survive
and colonize the GI tract. Intestinal colonization of noso-
comial E. faecium strains is a first and key step that pre-
cedes clinical infection due to fecal contamination of
catheters or wounds, and in the minority of infections,
through bacterial translocation from the intestinal lumen
to extraintestinal sites [17,18]. It is not known which fac-
tors facilitate intestinal colonization of nosocomial E. fae-
cium strains. The enterococcal surface protein Esp, located
on a putative pathogenicity island [19,20], is specifically
enriched in hospital-acquired E. faecium and has been
identified as a potential virulence gene. Esp is involved in
biofilm formation [21] and its expression is affected by
changes in environmental conditions, being highest in
conditions that mimic the microenvironment of the
human large intestines: 37°C and anaerobioses [22]. Fur-
thermore, in one study, bloodstream isolates of E. faecium
enriched with esp  had increased adherence to human
colorectal adenocarcinoma cells (Caco-2 cells) [23], sug-
gesting a role of Esp in intestinal colonization. In contrast,
adherence of E. faecium to Caco-2 cell lines was not asso-
ciated with the presence of esp in another study [24]. In E.
faecalis, Esp is also located on a pathogenicity island,
although the genetic content and organization of the E.
faecium and E. faecalis PAI is different. Esp of E. faecalis is
also expressed on the surface of the bacterium [25,26] and
is important in colonization of urinary tract epithelial
cells [25]. By using a mouse model, Pultz et al. [27]
showed that Esp does not facilitate intestinal colonization
or translocation of E. faecalis in mice, however this does
not automatically predict a lack function for E. faecium
Esp in murine colonization. First data suggest that the
function of Esp in both enterococcal species might be dif-
ferent. Esp of E. faecium is clearly involved in biofilm for-
mation (see above) while there is controversy about the
role of E. faecalis Esp in biofilm formation [28-31]. Fur-
thermore, studies so far indicate that E. faecalis harbors
more virulence determinants then E. faecium. For
instance, besides Esp different determinants (GelE, BopD,
fsr locus, and bee locus) are putatively involved in biofilm
formation [32-34]. This suggests that virulence factors in
E. faecalis play somewhat redundant or partially overlap-
ping roles such that the absence of a single virulence fac-
tor, like Esp, has only minimal effect. To elucidate the role
of Esp of E. faecium in bacterial adhesion and intestinal
colonization, we studied an Esp mutant, constructed and
described recently [21], and its Esp expressing parent
strain for their ability to adhere to intestinal epithelial
cells and intestinal colonization by using Caco-2 cells and
a mouse model.
Results
Adherence assay to Caco-2 cells
To determine whether Esp contributes to adherence of
intestinal epithelial cells, the Esp expressing E. faecium
strain E1162, its isogenic Esp-deficient mutant
(E1162Δesp), and an E. faecium esp-negative strain (E135)
were investigated for their ability to adhere to differenti-
ated 14 days old Caco-2 cells. Strain E1162 exhibited high
adherence to Caco-2 cells, while the esp-negative strain,
E135, showed only low-level binding to Caco-2 cells (Fig-
ure 1). This difference in adherence was significant (P <
0.005). However, no significant difference in adherence to
Caco-2 cells was observed between E1162 and E1162Δesp.
Intestinal colonization
To investigate the role of Esp in intestinal colonization
and translocation to MLN, the Esp expressing E1162 and
its isogenic Esp-deficient mutant (E1162Δesp) were inocu-
lated orally in mice separately or simultaneously in a
mixed inoculum. Mice were kept under ceftriaxone treat-
Adherence to Caco-2 cells Figure 1
Adherence to Caco-2 cells. Adherence of E135 (grey 
bars), E1162 (black bars) and E1162Δesp (white bars) to dif-
ferentiated Caco-2 cells (14 days old). Adherence levels are 
expressed as the mean number of CFU per ml ± the standard 
deviation (SD).
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ment the entire experiment. Prior to any intervention no
E. faecium was cultured from stools of mice. The mean
enterococcal contents of the stool of naïve mice was 5 ×
105 ± 2 × 105 CFU/gram, these colonies were specified
being E. faecalis.
Both E1162 and E1162Δesp  were able to colonize the
intestinal tract with comparable high numbers of cells for
the entire 10 days of the experiment. One day after inocu-
lation E1162 reached a median of 5.2 (range 2–15) × 108
CFU/gram of stool and E1162Δesp of 5.1 (1.6 – 8.2) × 108
CFU/gram. Ten days after inoculation, the amount of
both strains slightly reduced to 3.7 (1.3–10) × 106 and 2.7
(0.2–25) × 106 CFU/gram of stool, respectively (Figure
2A). Similar amounts of E1162 and E1162Δesp  were
found in the stool of mice colonized when the mixed
inoculum was administered (data not shown). After 10
days of colonization, all mice were sacrificed and E. fae-
cium  colonies obtained from small bowel, cecum, and
colon contents were calculated. In both cecum and colon
comparable amounts of E1162 (cecum contents 6.9
(0.04–7.3) × 106 and colon contents 3.9 (1.3–11) × 106
CFU/gram) and E1162Δesp (cecum contents 10 (0.4–200)
× 106 and colon contents 2.7 (0.2–24) × 106 CFU/gram)
were isolated, from both separate (Figure 2B) and mixed
inocula (data not shown). Significantly more E1162Δesp
(8.4 (0.5–300) × 106 CFU/gram) compared to E1162 (6.5
(0.5–52) × 104 CFU/gram) was isolated from the small
bowel contents of mice when inoculated separately with
E1162 wild type and the Esp-mutant strain (p = 0.002).
This difference was not found in mice inoculated with the
mixture of E1162 and E1162Δesp (data not shown).
Both E1162 and E1162Δesp were able to translocate to the
MLN. From both of the separately inoculated groups of
mice, three out of seven MLN were found positive for
either E1162 or E1162Δesp. No bacteria were cultured
from blood. No pathological changes in the intestinal
wall were observed in any of the colonized mice.
For both mono infection and mixed infection, randomly
picked colonies were tested by MLVA to confirm strain
identity. All colonies had the same MLVA profile belong-
ing to E. faecium E1162(Δesp).
Discussion
Nosocomial E. faecium infections are primarily caused by
specific hospital-selected clonal lineages, which are genet-
ically distinct from the indigenous enterococcal flora.
High rates of colonization of the GI tract of patients by
these hospital-selected lineages upon hospitalization have
been documented [13,15]. Once established in the GI
tract these nosocomial strains can cause infections
through bacterial translocation from the GI tract to
extraintestinal sites [35,36]. The mechanism which pro-
motes supplementation of the commensal enterococcal
population by these nosocomial strains is not known.
Destabilization of the GI tract through antibiotic therapy
may provide nosocomial strains enhanced opportunities
to gain a foothold in the GI tract. However, the effect of
Intestinal colonization Figure 2
Intestinal colonization. Mice were orally inoculated with E1162 (black circles) or E1162Δesp (open circles). (A) Numbers of 
E1162 and E1162Δesp were determined in stool of mice at different time points after E. faecium inoculation. (B) After 10 days 
of colonization, numbers of E1162 and E1162Δesp were determined in small bowel, cecum and colon. Data are expressed as 
CFU per gram of stool/fecal contents and medians are shown for 7 mice per group.
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antibiotics is probably not the sole explanation for the
emergence of nosocomial E. faecium infections since
many antibiotics used in hospitals have relatively little
enterococcal activity. This implicates that nosocomial E.
faecium strains may possess traits that facilitate coloniza-
tion of portions of the GI tract that the indigenous flora
cannot effectively monopolize. Cell surface proteins like
Esp, implicated in biofilm formation and specifically
enriched in nosocomial strains, could represent one of
these traits. Previously, it was shown that E. faecium is able
to adhere to human and mouse intestinal mucus in vitro
and becomes associated in vivo with the intestinal mucus
layer of clindamycin treated mice [37-39]. This suggests
an interaction between the bacterium and the mucus or
with the epithelium itself. To examine the role of Esp in
intestinal adherence and colonization, an Esp expressing
strain of E. faecium (E1162) and its isogenic Esp-deficient
mutant (E1162Δesp) were studied for adherence to differ-
entiated Caco-2 cells and colonization of murine intes-
tines. E1162, a hospital-acquired strain, exhibited
significantly higher adherence to Caco-2 cells than E135,
a representative of the indigenous flora. These results are
consistent with an earlier study performed by Lund et al.
[23]. However, no difference in adherence to Caco-2 cells
between the E1162 and the E1162Δesp was found, indicat-
ing that Esp is not the determining factor responsible for
the observed difference in Caco-2 cell adherence between
nosocomial and indigenous E. faecium strains. This also
implies that other determinants present in hospital-
acquired E. faecium strains contribute to adhesion to intes-
tinal epithelial cells. Comparative genomic hybridizations
of 97 E. faecium nosocomial, commensal and animal iso-
lates identified more than 100 genes that were enriched in
nosocomial strains, including genes encoding putative
adhesins, antibiotic resistance, IS elements, phage
sequences, and novel metabolic pathways [40].
In addition, similar levels of intestinal colonization or
translocation were found after inoculation with E1162
wild type or the isogenic Esp mutant E1162Δesp. These
data are in accordance with a study performed by Pultz et
al. [27] in which they showed that Esp did not facilitate
intestinal colonization or translocation of E. faecalis in
clindamycin-treated mice. Only from the small bowel
contents of mice when inoculated separately with E1162
wild type and the Esp-mutant strain significantly more
E1162Δesp compared to E1162 was isolated. This was an
unexpected observation and we have no explanation for
the fact that the levels of E1162Δesp in the small bowel are
as high as in the cecum. Relatively lower levels as seen for
E1162 are more typical for the small bowel.
Conclusion
Our data clearly demonstrate that Esp is not essential for
high density colonization of the GI tract by nosocomial
strains. Other possible candidate traits implicated in this
process could include novel adhesins, like the novel cell
surface proteins recently identified [41], bacteriocins, fac-
tors that resist specific or non-specific host defence mech-
anisms, and/or the ability to utilize new growth
substrates. It is interesting in this respect that we recently
identified a novel genomic island highly specific for noso-
comial strains that tentatively encodes novel sugar uptake
system [42].
For nosocomial E. faecium clones the GI tract serves as
staging area from which they can disperse in and between
patients, ultimately causing hospital-wide outbreaks. It is
therefore of utmost importance to gain insight into the
processes and determinants that promote intestinal colo-
nization of nosocomial E. faecium strains. Only then we
will be able to impede subsequent spread of these noso-
comial clones.
Methods
Bacterial strains and growth conditions
In this study E. faecium strains E135, E1162 and
E1162Δesp were used. E135 is an esp negative community
surveillance feces isolate, while strain E1162 is a hospital-
acquired blood isolate, positive for Esp expression. The
isogenic Esp-deficient mutant, E1162Δesp, was previously
constructed by introduction of a chloramphenicol resist-
ance cassette (cat) resulting in an insertion-deletion muta-
tion of the esp gene [21].E. faecium strains were grown in
either Todd-Hewitt (TH) or Brain Heart Infusion (BHI)
broth or on Tryptic Soy Agar (TSA) with 5% sheep red
blood cells (Difco, Detroit, MI). Slanetz and Bartley (SB)
agar plates were used to selectively grow enterococci. E.
faecium strain E1162 and its isogenic mutant are high-
level resistant to ceftriaxone (minimum inhibitory con-
centration > 32 μg/ml).
Caco-2 cell cultures
Human colorectal adenocarcinoma cells, Caco-2 cells,
were obtained from the American Type Culture Collection
(HTB-37, ATCC, USA) and were cultured in Dulbecco's
Modified Eagle Medium (DMEM; Gibco, Invitrogen, Pais-
ley, UK) supplemented with 10% heat-inactivated fetal
calf serum (Integro B.V, Zaandam, The Netherlands), 1%
non-essential amino acids (Gibco), 2 mM glutamine
(Gibco), and 50 μg/ml gentamicin (Gibco). Cells were
collected every 7th day by washing the monolayer twice
with 0.022% disodium-ethylenediamine tetra acetic acid
(di-Na-EDTA; Acros Organics, Morris Plains, NJ) in PBS
and trypsinizing the cells using 50 μg/ml trypsine
(Gibco), in 0.022% di-Na-EDTA in PBS. Cells were seeded
at 1 × 106 cells in 10 ml DMEM in 75 cm2 culture bottles
(Costar, Corning, NY) and incubated in a humidified,
37°C incubator with 5% CO2. The culture medium was
refreshed every 4th day after passage of the cells. Differen-BMC Microbiology 2009, 9:19 http://www.biomedcentral.com/1471-2180/9/19
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tiated Caco-2 cells were prepared by seeding cells from
passage 25 to 45 in 12-wells tissue culture plates (Costar)
at 1.6 × 105 cells/ml in DMEM. To each well 1 ml of this
suspension was added and plates were incubated at 37°C
with 5% CO2 for 14–16 days before use to allow the Caco-
2 cells to differentiate. The medium in the wells was
replaced by fresh medium three times a week.
Adherence assay
Overnight-grown cultures of E135, E1162 and E1162Δesp
in BHI broth were diluted (1:50) and grown at 37°C to an
OD660 of 0.4, while shaking. Bacteria were harvested by
centrifugation (6,500 × g; 3 min) and resuspended in
DMEM to a concentration of 1 × 107 CFU/ml. For each
strain, 1 ml bacterial suspension was added to the wells
(100 bacteria to 1 Caco-2 cell). Plates were centrifuged
(175 × g; 1 min) and incubated for 1 h at 37°C in 5% CO2
to allow adherence to the Caco-2 cells. After incubation,
monolayers were rinsed 3 times with DMEM and cells
were lysed with 1% Triton X-100 (Merck, Darmstadt, Ger-
many) in PBS for approximately 5 min at room tempera-
ture. Adherent bacteria were quantified by plating serial
dilutions onto TSA plates and counting resultant colonies.
Also the inoculum was plated to determine viable counts.
The assay was performed simultaneously in 3 separate
wells in duplicate and repeated on 3 different days.
Mice
Specific pathogen-free 10-week-old female C57BL/6 mice
(14 mice in total) were purchased from Harlan Sprague-
Dawley (Horst, The Netherlands). The animals were
housed in individual cages in rooms with a controlled
temperature and a 12-h light-dark cycle. They were accli-
matized for 1 week prior to usage, and received standard
rodent chow and water ad libitum. The Animal Care and
Use Committee of the University of Amsterdam approved
all experiments.
Induction of intestinal colonization
Mice were administered subcutaneous injections of ceftri-
axone (Roche, Woerden, The Netherlands; 100 μl per
injection, 12 mg/ml) 2 times a day, starting 2 days before
inoculation of bacteria and continuing for the duration of
the experiment. Two days after the initiation of the antibi-
otic treatment 2 × 109 CFU of E1162 or E1162Δesp in 300
μl TH broth was inoculated by orogastric inoculation
using an 18-gauge stainless animal feeding tube. In addi-
tion, in one experiment mice were administered a mixture
of an equal amount (1.5 × 109  CFU) of E1162 and
E1162Δesp  simultaneously. For all experiments, plate-
grown bacteria were inoculated in TH broth and grown at
37°C to an OD620 1.0, while shaking. The inoculum was
plated to determine viable counts. Mice were sacrificed
after 10 days of colonization. Seven mice per group were
examined.
Collection of samples
Stool samples were collected from naive mice, 2 days after
antibiotic treatment and 1, 3, 6 and 10 days after bacterial
inoculation. Per mice, 2 stool pellets were collected,
pooled, weighed (50–129 mg), and 1 ml of sterile saline
was added. After 10 days of colonization mice were anes-
thetized with Hypnorm® (Janssen Pharmaceutica, Beerse,
Belgium; active ingredients fentanyl citrate and flu-
anisone) and midazolam (Roche, Meidrecht, The Nether-
lands), blood was drawn by cardiac puncture and
transferred to heparin-gel vacutainer tubes. Mesenteric
lymph nodes (MLN) were excised, weighed and collected
in 4 volumes of sterile saline. Subsequently, the intestines
were excised, opened and fecal contents of small bowel,
cecum, and colon were weighed and 1 ml of sterile saline
was added.
Determination of bacterial outgrowth
The number of E. faecium CFU was determined in stool,
MLN, blood, and fecal contents of small bowel, cecum,
and colon. Stool, MLN, and fecal contents were homog-
enized at 4°C using a tissue homogenizer (Biospec
Products, Bartlesville, UK). CFU were determined from
serial dilutions of the homogenates and undiluted
blood. Twenty μl of each dilution and 50 μl of undi-
luted blood, was plated onto SB agar plates and grown
at 37°C for 44 h with 5% CO2. Colonies were counted,
tested by PCR to confirm species identity, and corrected
for the dilution factor to calculate CFU per gram of
stool/MLN/fecal contents. MLVA was performed to
confirm strain identity.
PCR analysis to confirm species
Stool samples from naïve mice and from mice treated for
2 days with ceftriaxone were examined for presence of E.
faecium. The lowest dilutions of stool homogenates that
contained well-separated colonies were chosen and each
colony of that dilution (12–24 CFU/20 μl diluted stool
homogenate) was tested by PCR for presence of the
housekeeping gene ddl  (encoding D-alanine, D-alanine
ligase) using the E. faecium specific primers ddlF (5'-GAG
ACA TTG AAT ATG CCT) and ddlR (5'-AAA AAG AAA TCG
CAC CG) [43]. The colonies were directly diluted in 25-μl-
volumes with HotStarTaq Master Mix (QIAQEN Inc.,
Valencia, CA). PCR's were performed with a 9800 Fast
Thermal Cycler (Applied Biosystems, Foster City, CA) and
the PCR amplification conditions were as follows: initial
denaturation at 95°C for 15 min, followed by 10 touch-
down cycles starting at 94°C for 30 s, 60°C for 30 s, and
72°C (the time depended on the size of the PCR product)
with the annealing temperature decreasing by 1°C per
cycle, followed by 25 cycles with an annealing tempera-
ture of 52°C. All primers used in this study were pur-
chased from Isogen Life Science (IJselstijn, The
Netherlands).BMC Microbiology 2009, 9:19 http://www.biomedcentral.com/1471-2180/9/19
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For mono infection, colonies obtained from stool (1, 3, 6,
and 10 days after bacterial inoculation), MLN, and fecal
contents from small bowel, cecum, and colon were exam-
ined to confirm species identity. Colonies were randomly
picked and presence of the ddl gene, in case E1162 was
inoculated, or the cat gene, in case E1162Δesp was inocu-
lated, was assessed by PCR using primer pairs ddlF – ddlR
and CmF (5'-GAA TGA CTT CAA AGA GTT TTA TG) –
CmR (5'-AAA GCA TTT TCA GGT ATA GGT G) [21],
respectively. When both strains were inoculated simulta-
neously, all colonies from the lowest dilution with well-
separated colonies were picked (3–28 CFU/20 μl diluted
homogenate). Species identity and the number of E1162
and E1162Δesp were determined by multiplex PCR using
primer pairs ddlF – ddlR and CmF – CmR. In PCR's, a col-
ony of E1162 and E1162Δesp was used as positive control
and a colony of E. faecalis V583 [44] was used as negative
control.
MLVA to confirm strain identity
For both mono infection and mixed infection, colonies
obtained from stool (1, 3, 6, and 10 days after bacterial
inoculation), MLN, and fecal contents from small bowel,
cecum, and colon were randomly picked and MLVA was
performed to confirm strain identity. MLVA was per-
formed as described previously [45].
Histological examination
Small bowel, cecum and colon tissue were fixed in 4%
buffered formalin and embedded in paraffin. Four-
micrometer-thick sections were stained with hematoxylin-
eosin and analyzed.
Statistical analysis
Adherence data are expressed as the mean CFU per ml ±
the standard deviation (SD). A two-tailed Student's t test
was applied. Mouse colonization data are expressed as
medians of CFU per gram of stool/fecal contents. Two
group comparisons were done by Mann-Whitney U test. A
p-value < 0.05 was considered statistically significant.
Abbreviations
Esp: enterococcal surface protein; GI tract: gastrointestinal
tract; Caco-2 cells: human colorectal adenocarcinoma
cells; MLN: mesenteric lymph nodes; CFU: colony form-
ing units; PCR: polymerase chain reaction; MLVA: Multi-
ple-Locus Variable-Number Tandem Repeat Analysis.
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